Literature DB >> 17931100

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis.

Richard Eastell, Rosemary A Hannon, Patrick Garnero, Michael J Campbell, Pierre D Delmas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17931100     DOI： 10.1359/jbmr.07090b

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  20 in total

Review 1.  Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy.

Authors:  John T Schousboe; Douglas C Bauer
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

2.  Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective.

Authors:  Mary L Bouxsein; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

Review 3.  Bone markers in osteoporosis.

Authors:  Patrick Garnero
Journal:  Curr Osteoporos Rep       Date:  2009-09       Impact factor: 5.096

4.  Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density.

Authors:  J Natsag; M A Kendall; D E Sellmeyer; G A McComsey; T T Brown
Journal:  HIV Med       Date:  2015-07-16       Impact factor: 3.180

5.  The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study.

Authors:  S J Bae; S H Lee; S H Ahn; H-M Kim; B-J Kim; J-M Koh
Journal:  Osteoporos Int       Date:  2016-03-16       Impact factor: 4.507

6.  Efficacy of intravenously administered ibandronate in postmenopausal Korean women with insufficient response to orally administered bisphosphonates.

Authors:  Sung Jin Bae; Beom-Jun Kim; Kyeong Hye Lim; Seung Hun Lee; Hong Kyu Kim; Ghi Su Kim; Jung-Min Koh
Journal:  J Bone Miner Metab       Date:  2012-05-19       Impact factor: 2.626

Review 7.  Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.

Authors:  Matthew B Greenblatt; Joy N Tsai; Marc N Wein
Journal:  Clin Chem       Date:  2016-12-09       Impact factor: 8.327

8.  Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.

Authors:  P Szulc; P D Delmas
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

Review 9.  The management of osteoporosis in children.

Authors:  L M Ward; V N Konji; J Ma
Journal:  Osteoporos Int       Date:  2016-04-28       Impact factor: 4.507

Review 10.  Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

Authors:  R G G Russell; N B Watts; F H Ebetino; M J Rogers
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.